News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Argos Therapeutics, Inc. (ARGS) To Host Post-American Society of Clinical Oncology Conference Call And Webcast, Monday, June 9, 2014


6/5/2014 9:25:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C., June 5, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that the Company will host a conference call and webcast on Monday, June 9, 2014 at 1 p.m. EDT. Robert A. Figlin, MD, FACP, professor of medicine and biomedical sciences, director of the Division of Hematology Oncology and deputy director at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute, along with Douglas C. Plessinger, RPh, Argos' vice president of clinical and medical affairs, will participate in the call to discuss data recently presented in mRCC at the 2014 ASCO annual meeting held in Chicago, IL from May 30 – June 3, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES